Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Metropolis Healthcare...

    Metropolis Healthcare $174 million IPO over subscribed

    GarimaWritten by Garima Published On 2019-04-06T09:06:46+05:30  |  Updated On 6 April 2019 9:06 AM IST
    Metropolis Healthcare $174 million IPO over subscribed

    New Delhi: Metropolis Healthcare Ltd's initial public offering (IPO) to raise as much as 12.04 billion rupees ($174.01 million)was oversubscribed 5.8 times at the end of the book-running process, stock exchange data showed on Friday.


    Of the 13.7 million shares the Indian diagnostics company intends to sell, promoter Sushil Kanubhai Shah will give up 6.3 million shares, while investor CA Lotus Investments, a unit of U.S.-based private equity firm Carlyle Group, will offload 7.4 million shares.


    The IPO includes an anchor portion of about 6 million shares.


    Read Also: Metropolis Healthcare gets SEBI nod, moves for Initial Public Offer


    Of the remaining shares, investors bid for about 44.6 million shares in the company, or 5.8 times the 7.7 million on offer, as of 0115 GMT.


    Interest for Indian equities has seen a rise recently as the country heads for its general elections next week, amid hopes that the current coalition government led by Prime Minister Narendra Modi would return to power, even though investors continued to maintain a cautious stance.


    Read Also: Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report


    Over the last month, India's state-owned Rail Vikas Nigam Ltd and the first ever real estate investment trust in India, Embassy Office Parks REIT have seen successful subscriptions.

    CA Lotus InvestmentsCarlyle GroupGMThealthhealth carehealth care govthealth care indiaHealthcare NewshelathcareIndiaIndian diagnostics companyinitial public offeringInvestment trustIPOMetropolisMetropolis HealthcareNarendra ModiPrime MinisterRail Vikas Nigam LtdREITSushil Kanubhai Shah
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok